Abstract
Human biomonitoring results can be used to evaluate prior metals exposures but the data production must adhere to rigorous scientific standards including validation of the analytical method and calculation of the methods uncertainty. The whole procedure is often perceived as a difficult and time-consuming task. The aim of this paper was to in house validate a sector field inductively coupled plasma mass spectrometry-based method and to speed up the calculation of measurements uncertainty in the monitoring of As, Be, Cd, Co, Cr, Hg, Ir, Mn, Mo, Ni, Pb, Pd, Pt, Rh, Sb, Sn, Tl, U, V and W in human blood. The laboratory validation was organized so as to vary the most representative factors (operators, time, materials, instrumental settings, calibrations) that could affect the analytical data. Then, only those sources that significantly affected the final result were considered in the uncertainty estimate, simplifying so the process. Validation data in blood were: linearity, R2 > 0.9992 over two orders of concentration; detection limits between 0.0015 μg L-1 - 1.03 μg L-1; mean trueness on certified reference materials between 91.2%-109.6%; mean recovery on spikes ranging 92%-105%; repeatability from 3.0% to 6.3% and reproducibility from 3.8% to 9.2%. The expanded uncertainty budget derived from two sources (reproducibility and trueness/recovery) was between 11% and 26%. Applying the proposed procedure in future biomonitoring studies for metals exposure will allow the production of analytical data of high quality and reliability. This is also crucial to correctly interpret the biomonitoring data with respect to statutory limits, reference limits and measures produced by other laboratories.
Keywords: Method validation, Uncertainty estimation, Metals, Human blood, Biomonitoring, SF-ICP-MS, Limit of detection, Limit of quantification, Multi-point calibration, Calibration Parameters, TRP modulators for pain indications, inflammatory and neuropathic pain, urinary incontinence, painful bladder syndrome, prostate cancer
Current Analytical Chemistry
Title: Monitoring of Environmental Metals in Human Blood: The Need for Data Validation
Volume: 7 Issue: 4
Author(s): Beatrice Bocca, Daniela Mattei, Anna Pino and Alessandro Alimonti
Affiliation:
Keywords: Method validation, Uncertainty estimation, Metals, Human blood, Biomonitoring, SF-ICP-MS, Limit of detection, Limit of quantification, Multi-point calibration, Calibration Parameters, TRP modulators for pain indications, inflammatory and neuropathic pain, urinary incontinence, painful bladder syndrome, prostate cancer
Abstract: Human biomonitoring results can be used to evaluate prior metals exposures but the data production must adhere to rigorous scientific standards including validation of the analytical method and calculation of the methods uncertainty. The whole procedure is often perceived as a difficult and time-consuming task. The aim of this paper was to in house validate a sector field inductively coupled plasma mass spectrometry-based method and to speed up the calculation of measurements uncertainty in the monitoring of As, Be, Cd, Co, Cr, Hg, Ir, Mn, Mo, Ni, Pb, Pd, Pt, Rh, Sb, Sn, Tl, U, V and W in human blood. The laboratory validation was organized so as to vary the most representative factors (operators, time, materials, instrumental settings, calibrations) that could affect the analytical data. Then, only those sources that significantly affected the final result were considered in the uncertainty estimate, simplifying so the process. Validation data in blood were: linearity, R2 > 0.9992 over two orders of concentration; detection limits between 0.0015 μg L-1 - 1.03 μg L-1; mean trueness on certified reference materials between 91.2%-109.6%; mean recovery on spikes ranging 92%-105%; repeatability from 3.0% to 6.3% and reproducibility from 3.8% to 9.2%. The expanded uncertainty budget derived from two sources (reproducibility and trueness/recovery) was between 11% and 26%. Applying the proposed procedure in future biomonitoring studies for metals exposure will allow the production of analytical data of high quality and reliability. This is also crucial to correctly interpret the biomonitoring data with respect to statutory limits, reference limits and measures produced by other laboratories.
Export Options
About this article
Cite this article as:
Bocca Beatrice, Mattei Daniela, Pino Anna and Alimonti Alessandro, Monitoring of Environmental Metals in Human Blood: The Need for Data Validation, Current Analytical Chemistry 2011; 7 (4) . https://dx.doi.org/10.2174/157341111797183119
DOI https://dx.doi.org/10.2174/157341111797183119 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
Bioanalytical and Biosensor Technologies for Target Molecules
Bioanalytical and biosensor technologies constitute the core of detecting and sensing diverse molecules within living organisms, encompassing proteins, DNA, small molecular metabolites, and beyond. These molecules assume pivotal roles in biological processes, rendering their analysis and sensing indispensable for comprehending biological phenomena and unraveling disease mechanisms. In the current landscape ...read more
Biogeochemistry: global environmental research and management
his issue focuses on the bio-pathways of trace elements (Ni, Co, Cr, Mn, Cd, Pb, Zn and REE) in soil, plant and atmospheric systems. Specific interest in the application of phytotechnologies that utilise hyperaccumulator plants (agro/phytomining). On the basis of understanding the migration and transformation of trace elements in ecosystem, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Benzofuran: A Key Heterocycle - Ring Closure And Beyond
Mini-Reviews in Organic Chemistry Clomiphene Citrate, Metformin or Both for Ovulation Induction in Therapy Naïve Women with Polycystic Ovary Syndrome (PCOS)? A Descriptive Review
Current Drug Therapy Integrin Function and Signaling as Pharmacological Targets in Cardiovascular Diseases and in Cancer
Current Pharmaceutical Design Patent Selections
Recent Patents on DNA & Gene Sequences Eph as a Target in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets β-Lactone Derivatives and Their Anticancer Activities: A Short Review
Current Topics in Medicinal Chemistry Therapeutic Targeting of G-Protein Coupled Receptor-Mediated Epidermal Growth Factor Receptor Transactivation in Human Glioma Brain Tumors
Mini-Reviews in Medicinal Chemistry Phosphorylation-Specific Prolyl Isomerase Pin1 as a new Diagnostic and Therapeutic Target for Cancer
Current Cancer Drug Targets Tumor Angiogenesis: A Potential Target In Cancer Control by Phytochemicals
Current Cancer Drug Targets Nuclear Long Non-Coding RNAs as Epigenetic Regulators in Cancer
Current Medicinal Chemistry Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
Current Drug Targets Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine Applications of HPLC-MALDI-TOF MS/MS Phosphoproteomic Analysis in Oncological Clinical Diagnostics
Current Proteomics Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells
Current Pharmaceutical Biotechnology Biomarker Assessment in Nutritional Modulation of Oxidative Stress-Induced Cancer Development by Lipid-Related Bioactive Molecules
Recent Patents on Anti-Cancer Drug Discovery The Putative Adverse Effects of Bisphenol A on Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs
Current Medicinal Chemistry Editorial (Hot Topic: Proceedings of the Fifth Stromboli Conference on Aging and Cancer "The Primeval Life-Generating Molecules. Therapeutic and Aging-Reversing Properties")
Current Aging Science